Degenerative Disc Disease (DDD) Procedure: Bone Marrow Concentrate that ... “Physical therapy plays a crucial role in the non-surgical management of spine problems. after the treatment Trained ...

H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating on FibroBiologics, Inc. (FBLG – Research Report) today and set a price ...

Among the patients who visit the hospital due to back pain, the most diagnosed disease is 'intervertebral disc ...

Research shows that 90% of individuals will experience some form of back pain in their lives, and among these, many could prevent chronic pain through preventive spine care. Clinically, spine health ...

NASS’s 2024 Research Funding Program announced grants and traveling fellowships winners totaling $159,059 this year.

The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance to a standalone lateral lumbar interbody fusion device from the internationally renowned surgeon Randal Betz, M.D.’s company, ...

OsteoAdapt SP demonstrated more robust and faster bone formation than the gold standard autograft in a large animal model of spinal fusion; The study demonstrated the safety and e ...

Constipation in Crohn’s disease may be caused by lifestyle and dietary factors, as well as medical conditions like strictures. Treatment may include eating more fiber, taking laxatives ...

Obeticholic acid, which is marketed as Ocaliva as a treatment for a type of liver disease known as primary biliary cholangitis, has come under scrutiny recently. Although the US Food and Drug ...

With early detection and personalised therapies, Artificial Intelligence (AI) can make a significant mark for the treatment of heart diseases in India, said experts on Sunday. Heart disease is a ...

Monopar Therapeutics has secured an exclusive global license from Alexion Pharmaceuticals to develop and commercialize ALXN-1840, a promising treatment for Wilson disease, following a successful ...

Agomab’s lead candidate is being investigated as a treatment for patients with fibrostenosing Crohn’s disease (FSCD). Credit: Hananeko_Studio via Shutterstock. Agomab Therapeutics has secured $89m in ...